BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18634690)

  • 1. Response: Is there a case for risk-based premiums in health care insurance?
    McGuire A
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):189-93; discussion 201-2. PubMed ID: 18634690
    [No Abstract]   [Full Text] [Related]  

  • 2. The case for risk-based premiums in public health insurance.
    Zweifel P; Breuer M
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):171-88. PubMed ID: 18634689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response: The case for risk-based subsidies in public health insurance.
    Van de Ven W
    Health Econ Policy Law; 2006 Apr; 1(Pt 2):195-9; discussion 201-2. PubMed ID: 18634691
    [No Abstract]   [Full Text] [Related]  

  • 4. Managing risk selection incentives in health sector reforms.
    Puig-Junoy J
    Int J Health Plann Manage; 1999; 14(4):287-311. PubMed ID: 11184915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Public and private health insurance in Germany: the ignored risk selection problem.
    Grunow M; Nuscheler R
    Health Econ; 2014 Jun; 23(6):670-87. PubMed ID: 23696240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal risk adjustment with adverse selection and spatial competition.
    Jack W
    J Health Econ; 2006 Sep; 25(5):908-26. PubMed ID: 16712986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cream-skimming, incentives for efficiency and payment system.
    Barros PP
    J Health Econ; 2003 May; 22(3):419-43. PubMed ID: 12683960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there evidence that recent consolidation in the health insurance industry has adversely affected premiums?
    Kopit WG
    Health Aff (Millwood); 2004; 23(6):29-31. PubMed ID: 15537582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk selection in a regulated health insurance market: a review of the concept, possibilities and effects.
    van Kleef RC; van de Ven WP; van Vliet RC
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):743-52. PubMed ID: 24219050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capping risk adjustment?
    Eugster P; Sennhauser M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):499-507. PubMed ID: 20462647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk adjustment in health insurance and its long-term effectiveness.
    Beck K; Trottmann M; Zweifel P
    J Health Econ; 2010 Jul; 29(4):489-98. PubMed ID: 20434784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementary health insurance as a tool for risk-selection in mandatory basic health insurance markets.
    Paolucci F; Schut E; Beck K; Gress S; Van de Voorde C; Zmora I
    Health Econ Policy Law; 2007 Apr; 2(Pt 2):173-92. PubMed ID: 18634661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biased selection within the social health insurance market in Colombia.
    Castano R; Zambrano A
    Health Policy; 2006 Dec; 79(2-3):313-24. PubMed ID: 16516333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community rating in health insurance and different benefit packages.
    Kifmann M
    J Health Econ; 2002 Sep; 21(5):719-37. PubMed ID: 12349879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Welfare effects of supplementary insurance: a comment.
    Danzon PM
    J Health Econ; 2002 Sep; 21(5):923-6. PubMed ID: 12349889
    [No Abstract]   [Full Text] [Related]  

  • 17. Managed competition: the future, not the past.
    Sipkoff M
    Manag Care; 2003 Aug; 12(8):24-7. PubMed ID: 12966847
    [No Abstract]   [Full Text] [Related]  

  • 18. [Notes on the planned German health fund model].
    Robra BP; Mayrhofer T
    Gesundheitswesen; 2006 Oct; 68(10):650-2. PubMed ID: 17099827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imperfect risk adjustment, risk preferences, and sorting in competitive health insurance markets.
    Layton TJ
    J Health Econ; 2017 Dec; 56():259-280. PubMed ID: 29248056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The perfect prescription for Iowa's health insurance market: competition.
    Stephenson LL
    Iowa Med; 2002; 92(6):18-20. PubMed ID: 12520620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.